<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Drug-Design on AI Digest</title><link>https://aidigest.kikihuang.net/tags/drug-design/</link><description>Recent content in Drug-Design on AI Digest</description><generator>Hugo</generator><language>zh-cn</language><lastBuildDate>Thu, 06 Aug 2026 00:00:00 +0800</lastBuildDate><atom:link href="https://aidigest.kikihuang.net/tags/drug-design/index.xml" rel="self" type="application/rss+xml"/><item><title>AI Builders 日报 · 2026-08-06</title><link>https://aidigest.kikihuang.net/posts/2026-08-06-daily/</link><pubDate>Thu, 06 Aug 2026 00:00:00 +0800</pubDate><guid>https://aidigest.kikihuang.net/posts/2026-08-06-daily/</guid><description>今天的 Builders 信号集中在三件事：AI 产品应先用 frontier model 验证体验、再优化成本；企业 AI 架构远未收敛，多模型与自建 orchestration 将长期并存；Chai Discovery 则把 scaling laws 带进药物设计，希望让分子研发从碰运气走向工程化。</description></item></channel></rss>